Table 3.
Adverse events associated with FLV and FLV+TJ-43 treatment.
FLV | FLV+TJ-43 | ||
Adverse events | Number (%) of patients reporting event | ||
GI symptoms | |||
Nausea | 9 (36) | center3 (12) | * |
Anorexia | 3 (12) | 3 (12) | |
Abdominal fullness | 1 (4) | 0 (0) | |
Constipation | 1 (4) | 0 (0) | |
Diarrhea | 1 (4) | 0 (0) | |
Feel discomfort | 3 (12) | 2 (8) | |
Feel irritable | 1 (4) | 0 (0) | |
Difficulty in urinating | 1 (4) | 0 (0) | |
General fatigue | 1 (4) | 0 (0) | |
Tremor | 0 (0) | 1 (4) | |
/25 | /25 |
FLV = fluvoxamine; TJ-43 = Rikkunshito; GI:gastrointestinal. * p < 0.05 by Fisher exact probability test.